Series B · BiotechSyneron Bio: Series BDevelops intelligent platform-driven macrocyclic peptide drug discoveryPublished Oct 4, 2026By RoundOS Funding deskFunding historyApr 3, 2026Series B · This round$150MSourcesprnewswire.com↗
De¹Building a Financial World Model trained on live market execution dataUndisclosedStrategic · Aug 28, 2026
OwnerProvides an AI-powered technology and marketing platform for local businesses$240MSeries D · Aug 28, 2026
MetriportOpen-source healthcare data infrastructure unifying patient records for clinicians$26MSeries A · Aug 27, 2026
AdvisarAI decisioning layer helping retail suppliers measure retail media investment ROI$750KPre-Seed · Aug 27, 2026